NCT00480805View on ClinicalTrials.gov

HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

August 8, 2001

Primary Completion Date

October 15, 2002

Study Completion Date

October 16, 2002

Conditions
Type 2 Diabetes MellitusHypertension
Interventions
DRUG

MK0954A, losartan potassium (+) hydrochlorothiazide (HYZAAR) / Duration of Treatment : 8 Weeks

DRUG

Comparator : ramipril /Duration of Treatment : 8 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00480805 - HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED) | Biotech Hunter | Biotech Hunter